8,517 articles
Peter E. Lipsky
Peter E. Lipsky is an American immunologist and rheumatologist known for the anti-TNF trials that established infliximab plus methotrexate for rheumatoid arthritis, and for B-cell research in lupus.
Peter F. Barnes
Peter F. Barnes is an American physician-scientist in infectious diseases known for tuberculosis research, including documenting the HIV-driven resurgence of tuberculosis and showing it spread mainly at Los Angeles homeless shelters.
Peter F. Cohn
Peter F. Cohn is a cardiologist and professor at Stony Brook University whose work on silent myocardial ischemia and noninvasive testing shaped post-infarction risk stratification.
Peter G. Davis
Peter G. Davis is an Australian neonatologist and researcher at the Royal Women's Hospital in Melbourne who has led more than 20 trials of newborn respiratory support.
Peter G. Pappas
Peter G. Pappas is an infectious-diseases physician and medical mycology researcher at the University of Alabama at Birmingham, known for leading the IDSA candidiasis guidelines and the Mycoses Study Group.
Peter Ganz
Peter Ganz is a cardiologist and Professor of Medicine at UCSF who directs vascular research at San Francisco General and pioneered endothelial biology and proteomics.
Peter George Ingle Stovin
Peter George Ingle Stovin was a British pathologist, born in Jinan, China, who co-described Hughes–Stovin syndrome in 1959 and worked on cardiac transplant pathology at Royal Papworth Hospital.
Peter Goadsby
Peter J. Goadsby is an Australian-born neurologist and headache researcher at King's College London whose CGRP work led to new migraine drugs; he shared the 2021 Brain Prize.
Peter Godfrey‐Faussett
Peter Godfrey-Faussett is an infectious-diseases physician-scientist and Emeritus Professor at the London School of Hygiene & Tropical Medicine, known for tuberculosis and HIV research in Zambia and South Africa.
Peter Goldman
Peter Goldman (1929–2017) was an American clinical pharmacologist and Harvard's Maxwell Finland Professor who pioneered the study of how gut bacteria metabolize drugs, notably sulfasalazine.
Peter H. Bennett
Peter H. Bennett is an American diabetes epidemiologist who began the landmark Pima Indian diabetes studies in 1965 and helped shape WHO diagnostic criteria adopted in 1980.
Peter H. Forsham
Peter H. Forsham was an American endocrinologist who directed UCSF's Metabolic Research Unit from 1952 to 1984, pioneering diabetes research and glucagon's role in diabetic ketoacidosis.
Peter H. Schur
Peter H. Schur is an American rheumatologist and clinical immunologist at Brigham and Women's Hospital and Harvard Medical School, known for linking anti-DNA antibodies and falling complement to lupus disease activity.
Peter H. Sönksen
Peter H. Sönksen is a British physician-scientist in endocrinology and diabetes, known for a 1989 growth hormone trial and for leading the GH-2000 anti-doping test group.
Peter H. Wiernik
Peter H. Wiernik is an American medical oncologist known for leukemia research, including the 1997 retinoic acid trial for acute promyelocytic leukemia and early clinical studies of paclitaxel.
Peter Hayes (hepatologist)
Peter Hayes, in full Peter Clive Hayes, is a British hepatologist, Professor of Hepatology at the University of Edinburgh, known for work on portal hypertension and acute liver failure.
Peter Hillmen
Peter Hillmen (P. Hillmen) is a British hematologist and Emeritus Professor at the University of Leeds known for the eculizumab trials that led to PNH approval in 2007.
Peter Hotez
Peter J. Hotez (born 1958) is an American vaccine scientist and pediatrician who leads the National School of Tropical Medicine at Baylor College of Medicine.
Peter J. Barnes
Peter J. Barnes, known in the literature as P. J. Barnes, is a British respiratory pharmacologist and Professor of Thoracic Medicine at Imperial College London, known for work on asthma and COPD.
Peter J. Campbell
Peter J. Campbell is a British cancer genomics researcher who coined chromothripsis and kataegis, headed the Sanger Institute's Cancer, Ageing and Somatic Mutation program, and left in 2024 for Quotient Therapeutics.
Peter J. Hutchinson
Peter J. Hutchinson is a British neurosurgeon and NIHR Research Professor at the University of Cambridge, known for leading the RESCUE trials on traumatic brain injury.
Peter J. Kahrilas
Peter J. Kahrilas is a gastroenterologist and Professor Emeritus at Northwestern University who led the Montreal Definition of GERD, the Chicago Classification, and the Lyon Consensus.
Peter J. Morris
Peter J. Morris (Sir Peter John Morris) was an Australian-born transplant surgeon who led Oxford's Nuffield Department of Surgery from 1974 to 2001 and pioneered transplant matching.
Peter J. Newman
Peter J. Newman is an American hematology researcher who discovered and characterized PECAM-1 (CD31), a cell adhesion molecule on platelets, and works at the Versiti Blood Research Institute in Milwaukee.
Peter J. O’Dwyer
Peter J. O'Dwyer is a medical oncologist, professor of medicine at the University of Pennsylvania, and co-chair of ECOG-ACRIN, known for gastrointestinal cancer research and the NCI-MATCH precision medicine trial.
Peter J. Polverini
Peter J. Polverini is an American oral and maxillofacial pathologist and cancer researcher who served as dean of the University of Michigan School of Dentistry from 2003 to 2013.
Peter J. Pronovost
Peter J. Pronovost is an American critical care physician and patient-safety researcher known for a central-line checklist that sharply reduced Michigan ICU infections, earning a MacArthur Fellowship in 2008.
Peter J. Quesenberry
Peter J. Quesenberry (1938–2025) was an American hematologist-oncologist and stem cell researcher at Brown University, known for the stem cell continuum and extracellular vesicle research.
Peter J. Roach
Peter J. Roach (1948–2022) was an English-born biochemist at the Indiana University School of Medicine who established the role of glycogen phosphorylation in Lafora disease.
Peter J. Sadler
Peter John Sadler is a chemist and Chair of Chemistry at the University of Warwick. He pioneered the chemistry of metals in medicine and developed targeted anticancer agents.